Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Semaglutide, a GLP-1 receptor agonist originally developed for type 2 diabetes, has become a popular medication for weight management
Some plans offering tiered options For employer-sponsored plans, some insurers are offering tiered options: Opt-in coverage: Employers can choose to cover GLP-1 drugs at an added cost
That said, we have no hard data on when this program will restart, if ever, or whether pricing will change
Per ADA guidelines, typical targets include fasting glucose of 80130 mg/dL and 12 hour postprandial values below 180 mg/dL for most adults
US$ 21.10
US$ 25.45
US$ 26.48
US$ 28.98
